A new drug shows promise against respiratory virus, study shows
CNN
A new antiviral medication against respiratory syncytial virus, or RSV, appears to be safe and lowered viral levels and symptoms significantly more than a placebo, according to the results of a study published Wednesday in The New England Journal of Medicine.
The study is unusual in that it is based on a two-part human challenge trial, where researchers purposefully infect people with a pathogen to test a new therapy. Challenge studies speed up research because scientists don't have to wait for their study participants to get sick out in the real world. They can also enroll fewer people, knowing that participants will inevitably catch a germ. But they're also risky and only considered ethical when the need for a new treatment or therapy is thought to outweigh the potential risks to study participants.
A winter virus that inundates pediatricians
Supreme Court majority appears skeptical of allowing Holocaust survivors to sue Hungary in US courts
A majority of the Supreme Court on Tuesday appeared skeptical that Holocaust victims and their families are permitted to haul Hungary into American courts to recover property stolen during World War II, with several justices fearing that would open the United States up to a flood of similar litigation from abroad.